Form 4: Agenus Inc. Insider Reports Stock Salary Payment

Garo H. Armen, Director and CEO of Agenus Inc., received 3,403 shares of common stock valued at $4.79 per share as payment for his salary.

Summary

• Garo H. Armen, a Director and Officer of Agenus Inc., received 3,403 shares of common stock on April 17, 2026.
• These shares were issued in lieu of cash salary for the pay period ending April 17, 2026, at a price of $4.79 per share.
• The shares are fully vested upon issuance and were granted under the Amended and Restated Agenus Inc. 2019 Equity Incentive Plan.
• Following this transaction, Mr. Armen beneficially owns 342,550 shares directly, 31,298 shares indirectly through his IRA, and 28,950 shares indirectly through the Garo Armen 2020 2 Year AG GRAT.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral; it reports a standard executive compensation transaction rather than significant financial performance or strategic shifts.

Positives

• Company is able to retain cash by paying executive salary in stock.
• Executive compensation is aligned with company stock performance.
• Shares issued are fully vested, providing immediate benefit to the executive.

Negatives

• The company is paying its CEO in stock, which could indicate cash flow constraints.
• The value of the stock received is tied to the market price on a specific date ($4.79), which may not reflect future performance.

Risks

• The company's ability to generate sufficient cash flow to meet operational needs and future obligations.
• Fluctuations in the market price of Agenus Inc. common stock could impact the perceived value of executive compensation.
• Potential for dilution of existing shareholders if a significant amount of stock is issued for compensation.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a change in beneficial ownership due to a salary payment.

Management Comments

• "At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash."
• "The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending April 17, 2026."
• "Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance."

Industry Context

StockSavvy.ai notes that paying executive salaries in stock is a common practice, particularly in growth-stage or cash-conscious biotechnology companies like Agenus Inc., to conserve cash and align executive incentives with shareholder interests.

Stakeholder Impact

• Shareholders: Potential for increased alignment of executive interests with shareholders, but also a signal of potential cash conservation measures by the company.
• Employees: May indicate a company culture that prioritizes equity and long-term growth, but could also be perceived as a sign of financial prudence that impacts cash availability for other employee-related initiatives.
• Creditors: The use of stock for compensation does not directly impact creditors but could indirectly affect the company's financial flexibility.

Next Steps

• Continued monitoring of Agenus Inc.'s financial health and stock performance.
• Observation of future executive compensation practices and potential cash flow management strategies.

Key Dates

Keywords

Form 4, Insider Trading, Stock Compensation, Executive Salary, Agenus Inc., AGEN, Beneficial Ownership, Equity Incentive Plan, Garo H. Armen